Emory University’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Emory University’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-59,690	Closed	-$1.41M	–	17
2019 Q3	$1.41M	Sell	59,690 -38,226	-39%	-$1.13M	2.78%	6
2019 Q2	$2.94M	Sell	97,916 -21,043	-18%	-$482K	2.07%	6
2019 Q1	$2.67M	Sell	118,959 -30,149	-20%	-$648K	1.87%	12
2018 Q4	$2.71M	Buy	+149,108	New	+$2.34M	2.14%	4
2017 Q4	–	Sell	-112,084	Closed	-$1.64M	–	55
2017 Q3	$1.64M	Buy	112,084 +48,940	+78%	+$740K	1.29%	42
2017 Q2	$1.18M	Sell	63,144 -40,462	-39%	-$913K	1.05%	52
2017 Q1	$2.21M	Buy	+103,606	New	+$1.98M	2.08%	10

Other funds holding RARX

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Emory University's RARX Position: Q4 2019 in Review

Emory University sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q4 2019, closing a stake of 59,690 shares — an estimated $1.41M sold.

Emory University first reported a position in RARX in Q1 2017 and held it in 7 quarters. The position peaked at $2.94M in Q2 2019. 146 funds tracked by Wall St. Rank hold RARX as of Q4 2019.

Emory University reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Emory University sold 59,690 Ra Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $1.41M.
Emory University first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2017 and held it in 7 quarters.
Emory University's Ra Pharmaceuticals, Inc. Common Stock position peaked at $2.94M in Q2 2019.
146 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Emory University's 13F filing for Q4 2019, filed 13 Feb 2020.